Patents by Inventor Steven Howard

Steven Howard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250149793
    Abstract: Routing and layout for an antenna are described. In one embodiment, the antenna comprises an aperture having a plurality of radio-frequency (RF) radiating antenna elements, wherein each antenna element of the plurality of RF radiating antenna elements comprises an iris slot opening and an electrode over the iris slot opening; a plurality of drive transistors coupled to the plurality of antenna elements; and a plurality of storage capacitors, each storage capacitor coupled to the electrode of one antenna element of the plurality of antenna elements. The aperture also comprises at least one of: the drive transistor for the one antenna element is located under the electrode of the antenna element, the storage capacitor for the one antenna element is located under the electrode of the antenna element, and the metal routing to the one antenna element for a first voltage overlaps, in an overlap region, a common voltage routing that routes the common voltage to the one antenna element to form a storage capacitance.
    Type: Application
    Filed: September 30, 2024
    Publication date: May 8, 2025
    Inventors: Cagdas Varel, Steven Howard Linn
  • Publication number: 20250151068
    Abstract: A system for 5G radio access networks, that enables smart RF signal repeater devices to perform many of the functions of a 5G base station to extend millimeter wave coverage for 5G communication networks while reducing costs, increasing versatility and optimizing coverage for user devices (UEs). The devices may include outdoor network repeaters and indoor subscriber repeaters, and other mmWave network transmitter devices in a mmWave network. Different types of 5G wireless communication networks may be employed including Open Radio Access Network (O-RAN), and Next Gen Radio Access Network (NG-RAN).
    Type: Application
    Filed: June 10, 2024
    Publication date: May 8, 2025
    Inventors: Eric James Black, Mersad Cavcic, Brian Mark Deutsch, Andjela Ilic-Savoia, Alexander Remley Katko, Steven Howard Ostroff, Colby John Harper
  • Publication number: 20250104913
    Abstract: A mount includes a rectangular shaped back surface configured to interface to a surface of a separate object, a first side surface perpendicular to the rectangular back surface and having a first arch-shaped cutout, and a second side surface perpendicular to the rectangular back surface and having a second arch-shaped cutout, wherein each of the first arch-shaped cutout and the second arch-shaped cutout comprises a first arch having a first radius and a second arch having a second radius, different from the first radius, the first radius of the first arch allows the mount to receive a cylindrical-shaped capacitor having a first diameter and the second radius of the second arch allows the mount to receive a cylindrical-shaped capacitor having a second diameter, different from the first diameter, and a channel configured to receive a strap and that extends through the mount, the channel having a closed channel portion, a first open channel portion, and a second open channel portion, wherein the strap extended t
    Type: Application
    Filed: September 20, 2024
    Publication date: March 27, 2025
    Inventors: Jonathan Coburn Charles, Christopher Roger Baron, Jeffrey Steven Howard
  • Publication number: 20250092027
    Abstract: The invention provides a compound of formula (1). or tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds.
    Type: Application
    Filed: July 9, 2024
    Publication date: March 20, 2025
    Applicants: ASTEX THERAPEUTICS LIMITED, CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Gianni CHESSARI, Steven HOWARD, Ildiko Maria BUCK, Benjamin David CONS, Christopher Norbert JOHNSON, Rhian Sara HOLVEY, David Charles REES, Jeffrey David ST. DENIS, Emiliano TAMANINI, Bernard Thomas GOLDING, Ian Robert HARDCASTLE, Celine Florence CANO, Duncan Charles MILLER, Martin Edward Mäntylä NOBLE, Roger John GRIFFIN, James Daniel OSBORNE, Joanne PEACH, Arwel LEWIS, Kim Louise HIRST, Benjamin Paul WHITTAKER, David Wyn WATSON, Dale Robert MITCHELL
  • Publication number: 20250074900
    Abstract: The invention relates to processes for preparing isoindolin-1-one derivatives, and in particular processes for preparing (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid. The invention also relates to crystalline forms of the compound (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid and its salts.
    Type: Application
    Filed: July 26, 2024
    Publication date: March 6, 2025
    Applicants: ASTEX THERAPEUTICS LIMITED, CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Steven HOWARD, Benjamin David CONS, Jeffrey David ST. DENIS, Charlotte Mary GRIFFITHS-JONES, Steven Douglas HISCOCK, Rhian Sara HOLVEY, Alan Richard BURNS, David COUSIN, Hannah Louise DEXTER, Guillaume François PARRA, John Paul WATTS, Robert JEWELL, Jennifer Ann STOCKWELL, Kim Louise HIRST, Isabelle Anne LEMASSON, David John NASH, James Daniel OSBORNE, Jonas Calleja PRIEDE, Nicholas Paul RICHARDS, Aaron Michael DUMAS, Brian Christopher BISHOP, David PARRY-JONES, Jeremy Peter SCOTT, Meenakshi Sundaram SHANMUGHAM, Peter Richard MULLENS, David Charles LATHBURY, Darren James DIXON, Matthew James GAUNT
  • Publication number: 20250051209
    Abstract: A glass manufacturing apparatus can include a conduit connected to a delivery vessel and an inlet of a forming vessel. The conduit includes a closed sidewall surrounding a channel extending in a flow direction of the conduit. The closed sidewall is continuous from the delivery vessel to the inlet of the forming vessel to define a closed atmosphere from the delivery vessel, through the conduit, and through the inlet of the forming vessel. The glass manufacturing apparatus can include a heating enclosure including a heating wall and a first heating element. The heating wall surrounds a chamber within which the conduit extends. The first heating element is positioned within the chamber between the heating wall and the conduit to increase a temperature within the channel. Methods for manufacturing a glass ribbon with a glass manufacturing apparatus are provided.
    Type: Application
    Filed: October 28, 2024
    Publication date: February 13, 2025
    Inventors: Alexey Sergeyevich Amosov, Michael Charles Gerrish, Vladislav Yuryevich Golyatin, Bulent Kocatulum, Steven Howard Tarcza, William Anthony Whedon
  • Patent number: 12217322
    Abstract: An example system is configured for displaying enhancement options and financial analysis. The system may include a server, third party data sources and an augmented reality computing device that includes a processing unit and system memory. The augmented reality computing device is configured to obtain user input regarding a property enhancement option; render the property enhancement options in augmented reality; obtain financial data from the server and the third party data sources; responsive to the obtained user input, automatically generate a financial analysis of the property enhancement option, wherein the financial analysis is based on the obtained financial data; and render the financial analysis with the obtained property enhancement option in augmented reality.
    Type: Grant
    Filed: September 14, 2023
    Date of Patent: February 4, 2025
    Assignee: Wells Fargo Bank, N.A.
    Inventors: Ankush Bhatia, Ricky Alan Brame, Wesley Damon Brown, Jan M. Emter, Paul Ferguson, Scott Curtis Grengs, Dan R. Grizzle, Dale Steven Howard, Basil F. Nimry, Suhas Dattatreya Sankolli
  • Patent number: 12202828
    Abstract: The invention relates to new bicyclic heterocycle compounds, to pharmaceutical compositions comprising the compounds and to the use of the compounds in the treatment of diseases, e.g. cancer.
    Type: Grant
    Filed: December 21, 2022
    Date of Patent: January 21, 2025
    Assignee: ASTEX THERAPEUTICS LIMITED
    Inventors: Gianni Chessari, Christopher Norbert Johnson, Steven Howard, James Edward Harvey Day, Ildiko Maria Buck, Charlotte Mary Griffiths-Jones, Gordon Saxty, Emiliano Tamanini, Nicola Elizabeth Wilsher
  • Patent number: 12151965
    Abstract: A glass manufacturing apparatus can include a conduit connected to a delivery vessel and an inlet of a forming vessel. The conduit includes a closed sidewall surrounding a channel extending in a flow direction of the conduit. The closed sidewall is continuous from the delivery vessel to the inlet of the forming vessel to define a closed atmosphere from the delivery vessel, through the conduit, and through the inlet of the forming vessel. The glass manufacturing apparatus can include a heating enclosure including a heating wall and a first heating element. The heating wall surrounds a chamber within which the conduit extends. The first heating element is positioned within the chamber between the heating wall and the conduit to increase a temperature within the channel. Methods for manufacturing a glass ribbon with a glass manufacturing apparatus are provided.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: November 26, 2024
    Assignee: CORNING INCORPORATED
    Inventors: Alexey Sergeyevich Amosov, Michael Charles Gerrish, Vladislav Yuryevich Golyatin, Bulent Kocatulum, Steven Howard Tarcza, William Anthony Whedon
  • Patent number: 12155197
    Abstract: A transformer assembly includes: a first switching apparatus configured to be electrically connected to a first segment of a transformer loop; a second switching apparatus configured to be electrically connected to a second segment of the transformer loop; and a transformer including: a first coil electrically connected to the first switching apparatus and the second switching apparatus; and a second coil electrically connected to an output configured to electrically connect to a load.
    Type: Grant
    Filed: December 8, 2021
    Date of Patent: November 26, 2024
    Assignee: Eaton Intelligent Power Limited
    Inventors: Samuel T. Reed, Steven Howard Buehler, Eduardo Muñoz Sampedro
  • Publication number: 20240368136
    Abstract: The invention provides a compound of formula (0): or a pharmaceutically acceptable salt, N-oxide or tautomer thereof; wherein: n is 1 or 2; X is CH or N; Y is selected from CH and C—F; Z is selected from C—Rz and N; R1 is selected from: -(Alk1)t-Cyc1; wherein t is 0 or 1; Optionally substituted C1-6 acyclic hydrocarbon groups R2 is selected from hydrogen; halogen; and C1-8 hydrocarbon groups optionally substituted with one or more fluorine atoms; R3 is hydrogen or a group L1-R7; R4 is selected from hydrogen; methoxy; and optionally substituted C1-3 alkyl; and R4a is selected from hydrogen and a C1-3 alkyl group; wherein Rz, Alk1, Cyc1, L1 and R7 are defined herein; provided that the compound is other than 6-benzyl-3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and 3-{2-[(2-methylpyrimidin-4-yl)amino]pyridin-4-yl}-7,8-dihydro-1,6-naphthyridin-5(6H)-one and salts and tautomers thereof.
    Type: Application
    Filed: October 19, 2023
    Publication date: November 7, 2024
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Valerio BERDINI, Ildiko Maria BUCK, James Edward Harvey DAY, Charlotte Mary GRIFFITHS-JONES, Thomas Daniel HEIGHTMAN, Steven HOWARD, Christopher William MURRAY, David NORTON, Marc O'REILLY, Alison Jo-Anne WOOLFORD, Michael Liam COOKE, David COUSIN, Stuart Thomas ONIONS, Jonathan Martin SHANNON, John Paul WATTS
  • Publication number: 20240350233
    Abstract: An orthodontic device can include a bracket configured to support an orthodontic wire. The orthodontic device can include a locking assembly coupled to the bracket and switchable between a plurality of operational modes. The plurality of operational modes can comprise a first sliding mode in which the orthodontic wire is slidable relative to the bracket and a second locked mode in which the orthodontic wire is slidably locked relative to the bracket.
    Type: Application
    Filed: July 2, 2024
    Publication date: October 24, 2024
    Inventors: Kami Hoss, Steven Howard, Jacob A. Moebius
  • Patent number: 12107348
    Abstract: Routing and layout for an antenna are described. In one embodiment, the antenna comprises an aperture having a plurality of radio-frequency (RF) radiating antenna elements, wherein each antenna element of the plurality of RF radiating antenna elements comprises an iris slot opening and an electrode over the iris slot opening; a plurality of drive transistors coupled to the plurality of antenna elements; and a plurality of storage capacitors, each storage capacitor coupled to the electrode of one antenna element of the plurality of antenna elements. The aperture also comprises at least one of: the drive transistor for the one antenna element is located under the electrode of the antenna element, the storage capacitor for the one antenna element is located under the electrode of the antenna element, and the metal routing to the one antenna element for a first voltage overlaps, in an overlap region, a common voltage routing that routes the common voltage to the one antenna element to form a storage capacitance.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: October 1, 2024
    Assignee: KYMETA CORPORATION
    Inventors: Cagdas Varel, Steven Howard Linn
  • Patent number: 12089871
    Abstract: A depth sensing dilator system for dilating a penetration in a tissue plane includes an elongate flexible body, having a proximal end and a distal end. The body has a tapered dilator segment, and at least a first electrode on a distal end of the body. The system includes a processor and a user interface output device. The processor is configured to send a first signal to the output device when a change in impedance at the first electrode indicates that the first electrode has reached a predetermined relationship with the tissue plane.
    Type: Grant
    Filed: August 25, 2021
    Date of Patent: September 17, 2024
    Assignee: Cross Vascular, Inc.
    Inventors: Steven Howard, Marshall L. Sherman, Randell Werneth, Bradley Klos
  • Patent number: 12077526
    Abstract: The invention relates to processes for preparing isoindolin-1-one derivatives, and in particular processes for preparing (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid. The invention also relates to crystalline forms of the compound (2S,3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[(1S)-1-hydroxy-1-(oxan-4-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]-2-methylpropanoic acid and its salts.
    Type: Grant
    Filed: January 25, 2023
    Date of Patent: September 3, 2024
    Assignees: ASTEX THERAPEUTICS LIMITED, CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Steven Howard, Benjamin David Cons, Jeffrey David St. Denis, Rhian Sara Holvey, Guillaume François Parra, Kim Louise Hirst, Isabelle Anne Lemasson, David John Nash, James Daniel Osborne, Jonas Calleja Priede, Nicholas Paul Richards, Aaron Michael Dumas, Brian Christopher Bishop, David Parry-Jones, Meenakshi Sundaram Shanmugham, Darren James Dixon, Matthew James Gaunt
  • Patent number: 12071429
    Abstract: The invention provides a compound of formula (I): or tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the various substituents are as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: August 27, 2024
    Assignees: ASTEX THERAPEUTICS LIMITED, CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Gianni Chessari, Steven Howard, Ildiko Maria Buck, Benjamin David Cons, Christopher Norbert Johnson, Rhian Sara Holvey, David Charles Rees, Jeffrey David St. Denis, Emiliano Tamanini, Bernard Thomas Golding, Ian Robert Hardcastle, Celine Florence Cano, Duncan Charles Miller, Martin Edward Mäntylä Noble, Roger John Griffin, James Daniel Osborne, Joanne Peach, Arwel Lewis, Kim Louise Hirst, Benjamin Paul Whittaker, David Wyn Watson, Dale Robert Mitchell
  • Publication number: 20240262842
    Abstract: Compounds of Formula (I) or (Ia) or their pharmaceutically acceptable salts can inhibit the G12C mutant of Kirsten rat sarcoma (KRAS) protein and are expected to have utility as therapeutic agents, for example, for treating cancer. The disclosure also provides pharmaceutical compositions which comprise compounds of Formula (I) or (Ia) or pharmaceutically acceptable salts thereof. The disclosure also relates to methods for use of the compounds or their pharmaceutically acceptable salts in the therapy and prophylaxis of cancer and for preparing pharmaceuticals for this purpose.
    Type: Application
    Filed: April 27, 2022
    Publication date: August 8, 2024
    Inventors: Kazuaki SHIBATA, Hiroki Asakura, Kei AKEMOTO, Toshihiro SAKAMOTO, Hitomi KONDO, Tomohiro YAMAMOTO, Risako MIURA, Patrick SCHÖPF, Juan DEL POZO, George Madalin GIAMBUSU, Thomas H. GRAHAM, Yongxin HAN, Elisabeth T. HENNESSY, Anandan PALANI, Michael RYAN, David L. Sloman, Steven HOWARD
  • Publication number: 20240258677
    Abstract: Expansion compensation structures for an antenna are disclosed. In one embodiment, the antenna comprises: an array of antenna elements; and a structure coupled to the array of antenna elements, the structure having a plurality of components comprising materials having different coefficients of thermal expansion (CTEs), wherein first and second components of the plurality of components are pin bonded with one or more pins, and one or more components of the plurality of components other than the first and second components are between the first and second components and have one or more slots through which the one or more pins traverse and have CTEs different than CTEs of the first and second components.
    Type: Application
    Filed: February 5, 2024
    Publication date: August 1, 2024
    Inventors: Steven Howard Linn, Mehdi Afkhami Reihani, Stephen Olfert, Chris Eylander, Felix Chen, Corey Pfeiff, Jonathan Byron
  • Publication number: 20240245452
    Abstract: A transseptal crossing system can have a sheath and an elongate tubular body. The tubular body can include an electrically conductive sidewall defining a central lumen and a distal end section. The central lumen may be configured to receive a guidewire and to permit at least a portion of the guidewire to extend through a distal opening of the electrically conductive sidewall. The distal end section can comprise a distal end surface in electrical communication with the electrically conductive sidewall. The distal end surface includes a first section being positioned generally perpendicular to a longitudinal axis of the elongate tubular body and a second section being positioned at a non-orthogonal angle relative to the longitudinal axis of the elongate tubular body. At least one of the first section or the second section may be configured to deliver energy to a target tissue.
    Type: Application
    Filed: January 19, 2024
    Publication date: July 25, 2024
    Applicant: CIRCA SCIENTIFIC, INC.
    Inventors: Brian Schuler, Steven Howard, Keith Weier, Matthew Spencer Toone
  • Publication number: 20240239788
    Abstract: Compounds or their pharmaceutically acceptable salts can inhibit the G12D mutant of Kirsten rat sarcoma (KRAS) protein and are expected to have utility as therapeutic agents, for example, for treating cancer. The disclosure also provides pharmaceutical compositions which comprise compounds disclosed herein or pharmaceutically acceptable salts thereof. The disclosure also relates to methods for use of the compounds or their pharmaceutically acceptable salts in the therapy and prophylaxis of cancer and for preparing pharmaceuticals for this purpose.
    Type: Application
    Filed: April 15, 2022
    Publication date: July 18, 2024
    Inventors: David L. Sloman, Gianni Chessari, Patrick Schöpf, Steven Howard, Yuichi Kawai, Kazuaki Shibata, Hiroki Asakura, Takao Uno, Takeshi Sagara, Masayuki Nakamura, Yu Kobayakawa, David Jonathan Bennett, Indu Bharathan, Thomas H. Graham, Yongxin Han, Zahid Hussain, Xiaoshen Ma, Mihir Mandal, Ryan D. Otte, Anandan Palani, Uma Swaminathan, Mycah Uehling, Yingchun Ye, Ryan Chau, Alec H. Christian, Symon Gathiaka, Timothy J. Henderson, Elisabeth T. Hennessy, Andrew J. Hoover, Shuhei Kawamura, Igri Kolaj, Thomas W. Lyons, Matthew J. Mitcheltree, Aaron Sather